AURX
vs
REGN
AURX
REGN
Over the past 12 months, AURX has underperformed REGN, delivering a return of +5% compared to the REGN's +10% growth.
Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
Smart Verdict
AI-Powered
Let AI Decide.
AURX
REGN
Valuation Comparison
| Company | Last Price | Intrinsic Value | DCF Value | Relative Value | Wall St Target | ||
|---|---|---|---|---|---|---|---|
|
Nuo Therapeutics Inc
OTC:AURX
|
1.57
USD
|
|||||
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
751.45
USD
|
|||||
Compare the stock's valuation with its competitors.
Growth Comparison
Growth Over Time
AURX, REGN
Compare company's financials with its competitors.
| Company | LTM | Historical Growth | Growth Streak | % Positive Years | Max Drawdown | Volatility | Forecasted Growth | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 10 Years | 1 Year | 3 Years | ||||||||
|
Nuo Therapeutics Inc
Revenue
|
|||||||||||
|
Regeneron Pharmaceuticals Inc
Revenue
|
|||||||||||
All metrics are calculated based on data from the last 10 years.
Compare company's financials with its competitors.
Profitability Comparison
Free Cash Flow
AURX, REGN
Compare company's free cash flow with its competitors.
| Company | LTM | Average | Historical Growth | FCF Margin | Conversion | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 3 Years | 5 Years | 10 Years | ||||||
|
Nuo Therapeutics Inc
OTC:AURX
|
|||||||||
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
|||||||||
Compare company's free cash flow with its competitors.
Gross Margin
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
Nuo Therapeutics Inc | ||||
|
Regeneron Pharmaceuticals Inc | ||||
Operating Margin
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
Nuo Therapeutics Inc | ||||
|
Regeneron Pharmaceuticals Inc | ||||
Net Margin
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
Nuo Therapeutics Inc | ||||
|
Regeneron Pharmaceuticals Inc | ||||
FCF Margin
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
Nuo Therapeutics Inc | ||||
|
Regeneron Pharmaceuticals Inc | ||||
ROE
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
Nuo Therapeutics Inc | ||||
|
Regeneron Pharmaceuticals Inc | ||||
ROA
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
Nuo Therapeutics Inc | ||||
|
Regeneron Pharmaceuticals Inc | ||||
ROIC
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
Nuo Therapeutics Inc | ||||
|
Regeneron Pharmaceuticals Inc | ||||
ROCE
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
Nuo Therapeutics Inc | ||||
|
Regeneron Pharmaceuticals Inc | ||||
Solvency Comparison
Compare company's equity waterfall with its competitors.
Stocks Performance
Stocks Performance
AURX, REGN
Performance By Year
AURX, REGN
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.